RePORT ⟩ RePORTER

Project Details

MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 RESEARCH

Project Number272201600013C-P00031-9999-12

Contact PI/Project LeaderSTEDMAN, TIMOTHY

Awardee OrganizationAMERICAN TYPE CULTURE COLLECTION

Description

Abstract Text

This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and reference reagents to the research community. These reagents span the pathogens in the Division of Microbiology and Infectious Diseases portfolio, and include the National Institutes of Allergy and Infectious Disease (NIAID) Category A, B and C Priority Pathogens and emerging infectious diseases.

Public Health Relevance Statement

Data not available.

NIH Spending Category

Biodefense and Related CountermeasuresCoronavirusesEmerging Infectious DiseasesInfectious Diseases

Project Terms

2019-nCoVBasic ScienceCategoriesCommunicable DiseasesCommunitiesContractsEmerging Communicable DiseasesMicrobiologyNational Institute of Allergy and Infectious DiseaseProductionReagentResearchResourcesbiological researchpathogenpreservationpriority pathogenproduct developmentrepositoryresearch and development

Details

Contact PI/ Project Leader

Name

STEDMAN, TIMOTHY

Title

Contact

Other PIs

Not Applicable

Program Official

Name

Contact

Email not available

Organization

Name

AMERICAN TYPE CULTURE COLLECTION

City

MANASSAS

Country

UNITED STATES (US)

Department Type

Unavailable

Organization Type

Research Institutes

State Code

Congressional District

Other Information

Opportunity Number

Study Section

Fiscal Year

2023

Award Notice Date

Administering Institutes or Centers

National Institute of Allergy and Infectious Diseases

CFDA Code

DUNS Number

057954067

UEI

KT4MLLHK99V6

Project Start Date

05-May-2022

Project End Date

04-August-2023

Budget Start Date

Budget End Date

Project Funding Information for 2023

Total Funding

$3,186,892

Direct Costs

Indirect Costs

Year	Funding IC	FY Total Cost by IC
2023	National Institute of Allergy and Infectious Diseases	$3,186,892

NIH Categorical SpendingClick here for more information on NIH Categorical Spending

Funding IC	FY Total Cost by IC	NIH Spending Category
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES	$3,186,892	Biodefense and Related Countermeasures; Coronaviruses; Emerging Infectious Diseases; Infectious Diseases

Sub Projects

No Sub Projects information available for 272201600013C-P00031-9999-12

Publications

Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.

No Publications available for 272201600013C-P00031-9999-12

Patents

No Patents information available for 272201600013C-P00031-9999-12

Outcomes

The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.

No Outcomes available for 272201600013C-P00031-9999-12

Clinical Studies

No Clinical Studies information available for 272201600013C-P00031-9999-12

News and More

Section Menu